Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study

References

1. Arnon S.S., Mills D.C., Day P.A., Henrickson R.V., Sullivan N.M., Wilkins T.D. 1984; Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: physiologic and pathologic basis. Journal of Pediatrics 104:34–40
   [Google Scholar]
2. Banno Y., Kobayashi T., Kono H., Watanabe K., Ueno K., Nozawa T. 1984; Biochemical characterization and biologic actions of two toxins (D-l and D-2) from Clostridium difficile. Reviews of Infectious Diseases 6:S11–S20
   [Google Scholar]
3. Bartlett J.G. 1986; Clostridium difficile: pseudomembranous colitis and antibotic-associated diarrhea. In Infectious Diarrhea pp. 157–178 Gorbach S.L. Edited by Boston: Blackwell Scientific Publications;
   [Google Scholar]
4. Bartlett J.G., Chang T.W., Gurwith M., Gorbach S.L., Onderdonck A.B. 1978; Antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. New England Journal of Medicine 298:531–536
   [Google Scholar]
5. Castex F., Jouvert S., Bastide M. 1987; Visualization by scanning electron microscopy of the intestinal transit of Saccharo- myces boulardii in mice. Bulletin de la Société Française de Mycologie Médicate 16:249–256
   [Google Scholar]
6. Castex F., Jouvert S., Bastide M. 1988; Kinetics of elimination of Saccharomyces boulardii in the mouse ileum: visualization by scanning electron microscopy. Revista Iberica de Micologia 5: (suppl.), 28 (Abstract)
   [Google Scholar]
7. Corthier G., Dubos F., Raibaud P. 1985; Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria. Applied and Environmental Microbiology 49:250–252
   [Google Scholar]
8. Corthier G., Dubos F., Ducluzeau R. 1986; Prevention of Clostridium difficile-induced mortality in gnotobiotic mice by Saccharomyces boulardii. Canadian Journal of Microbiology 32:894–896
   [Google Scholar]
9. Corthier G., Muller M.C., Elmer G.W., Lucas F., Dubos-Ramaré F. 1989; Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic mice. Infection and Immunity 57:3922–3927
   [Google Scholar]
10. Czuprynski C.J., Johnson W.J., Balish E. 1983; Pseudomembranous colitis in Clostridium difficile monoassociated rats. Infection and Immunity 39:1368–1376
    [Google Scholar]
11. Elmer G.W., Mcfarland L.V. 1987; Saccharomyces boulardii suppression of overgrowth of toxigenic Clostridium difficile following vancomycin treatment in the hamster. Antimicrobial Agents and Chemotherapy 31:129–131
    [Google Scholar]
12. Libby J.M., Jortner B.S., Wilkins T.D. 1982; Effect of two toxins of Clostridium difficile in antibotic-associated cecitis in hamsters. Infection and Immunity 36:822–829
    [Google Scholar]
13. Lima A.A.M., Lyerly D.M., Wilkins T.D., Innes D.J., Guerrant R.L. 1988; Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infection and Immunity 56:582–588
    [Google Scholar]
14. Lonnroth I., Lange S. 1983; Toxin A of Clostridium difficile '. production, purification and effect in mouse intestine. Acta Pathologica et Microbiologica Scandinavica 91:395–400
    [Google Scholar]
15. Lyerly D.M., Wilkins T.D. 1984; Characteristics of the toxins of Clostridium difficile. . In Antibiotic-associated Diarrhea and Colitis pp. 89–102 Borriello S.P. Edited by Boston: Martinus Nijhoff;
    [Google Scholar]
16. Lyerly D.M., Saum K.E., Macdonald D.K., Wilkins T.D. 1985; Effects of Clostridium difficile toxins given intragastrically to animals. Infection and Immunity 47:349–352
    [Google Scholar]
17. Lyerly D.M., Phelps C.J., Toth J., Wilkins T.D. 1986; Characterization of toxin A and B of Clostridium difficile with monoclonal antibodies. Infection and Immunity 54:70–76
    [Google Scholar]
18. Mahé S., Corthier G., Dubos F. 1987; Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice. Infection and Immunity 55:1801–1805
    [Google Scholar]
19. Massot J., Sanchez O., Couchy R., Astoin J., Parodi A.L. 1984; Bacterio-pharmacological activity of Saccharomyces boulardii in clindamycin-induced colitis in the hamster. ArzneimittelForschung 34:794–797
    [Google Scholar]
20. Meador J., Tweten R.K. 1988; Purification and characterization of toxin B from Clostridium difficile. Infection and Immunity 56:1708–1714
    [Google Scholar]
21. Mitchell T.J., Ketley J.M., Haslam S.C., Stephen J., Burdon D.W., Candy D.C.A., Daniel R. 1986; Effect of toxins A and B of Clostridium difficile on rabbit ileum and colon. Gut 27:78–85
    [Google Scholar]
22. Sullivan N.M., Pellett S., Wilkins T.D. 1982; Purification and characterization of toxins A and B of Clostridium difficile. Infection and Immunity 35:1032–1040
    [Google Scholar]
23. Toothaker R.D., Elmer G.W. 1984; Prevention of Clindamycin-induced mortality in hamster by Saccharomyces boulardii. Antimicrobial Agents and Chemotherapy 26:552–556
    [Google Scholar]
24. Vernet A., Corthier G., Dubos-Ramare F., Parodi A.L. 1989; Relationship between levels of Clostridium difficile toxin A and toxin B and cecal lesions in gnotobiotic mice. Infection and Immunity 57:2123–2127
    [Google Scholar]
25. Wilson K.H., Sheagren J.N., Freter R., Weatherbee L., Lyerly D. 1986; Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli. Journal of Infectious Diseases 153:547–551
    [Google Scholar]